Gallbladder carcinoma and surgical treatment

Area of Science:

• Gastroenterology
• Surgical Oncology
• Epidemiology

Background:

• Gallbladder carcinoma exhibits distinct geographic and demographic patterns, being more prevalent in specific regions and populations.
• It represents the most common malignancy of the biliary tract, occurring in 1-3% of biliary tract operations.
• Risk factors include chronic cholecystitis, choledochal cysts, obesity, female gender, advanced age, and exposure to carcinogens.

Purpose of the Study:

• To discuss the management of gallbladder cancer across different stages and clinical situations.
• To highlight diagnostic challenges and the importance of surgical intervention.

Main Methods:

• Review of epidemiological data and risk factors for gallbladder carcinoma.
• Analysis of diagnostic modalities like ultrasound and computed tomography (CT).
• Evaluation of surgical resection strategies, including hepatectomy and lymphadenectomy, and their impact on survival.

Main Results:

• Curative resection rates for gallbladder carcinoma range from 10% to 30%.
• Para-aortic lymphadenectomy offers no survival benefit for patients with para-aortic disease.
• Biopsy of para-aortic nodes before surgery is recommended due to frequent involvement.
• Palliative procedures and systemic therapies are options for unresectable or advanced cancers.

Conclusions:

• Survival is contingent on achieving curative resection, with stage-dependent treatment protocols.
• Management strategies must be tailored to the stage of gallbladder cancer, from early incidental findings to advanced disease.
• Further research is needed for optimal management of advanced gallbladder tumors with chemotherapy and chemoradiotherapy.